Real Housewives of Beverly Hills star Teddi Mellencamp, 43, was diagnosed 'multiple' brain tumors that may have been caused ...

While melanoma is much less common than other types of skin cancer, it is the most serious because it is more likely to ...

We think the strategy to find more effective combination therapies in hematology and build a larger oncology and dermatology portfolio is solid, although we're waiting for key data before assuming the ...

The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant ...

A study finds no elevated cancer risk in patients with vitiligo, with lower risks for melanoma, lung, and bladder cancers.

Individuals with vitiligo did not display a significantly increased risk for cancer compared with the general population, according to a study.“Traditionally linked to other autoimmune diseases, ...

Within the baricitinib group, patients experienced a mean Vitiligo Area Scoring Index score change of 44.8% from baseline to week 36. In contrast, the placebo group saw a 9.2% change. The Janus ...

"This proof-of-concept randomized clinical trial highlighted the efficacy of combining the JAK1/JAK2 inhibitor baricitinib with narrowband UVB in the treatment of adults with active vitiligo," the ...

In the clinical opinion of Lawrence F. Eichenfield, MD, pediatric patients with vitiligo would benefit from improved treatments and management strategies. “There is a tremendous variation in how ...

The success of biologic therapies in psoriasis has catalyzed the development of similar treatments for other chronic inflammatory diseases, including atopic dermatitis, hidradenitis suppurativa, lupus ...

The biologics license application for RP1 (vusolimogene oderparepvec) plus nivolumab in advanced melanoma was accepted by the FDA with priority review. The FDA accepted the biologics license ...

In a phase 2 clinical trial, researchers examined baricitinib and NB-UVB in adults with severe vitiligo in the dermatology departments at 4 hospitals in France between July 2021 and April 2023.